Veterinary and Comparative Oncology

Aims & Scope

Veterinary and Comparative Oncology (VCO) is an international, peer-reviewed journal integrating clinical and scientific information from a variety of related disciplines and from worldwide sources for all veterinary oncologists and cancer researchers concerned with aetiology, diagnosis and clinical course of cancer in domestic animals and its prevention.

With the ultimate aim of diminishing suffering from cancer, the journal supports the transfer of knowledge in all aspects of veterinary oncology, from the application of new laboratory technology to cancer prevention, early detection, diagnosis and therapy.

In addition to original articles, the journal publishes solicited editorials, review articles, commentary, correspondence and abstracts from the published literature.

Accordingly, studies describing laboratory work performed exclusively in purpose-bred domestic animals (e.g. dogs, cats, horses) will not be considered.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	1.9
2024	2.30

SJR (SCImago Journal Rank)

Year	Value
2024	0.892

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	52

Journal Rank

Year	Value
2024	5770

Journal Citation Indicator

Year	Value
2024	600

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Veterinary, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Cisplatin: a review of toxicities and therapeutic applications

  Citation: 368

  Authors: K., R., D., C.

• Response evaluation criteria for solid tumours in dogs (v1.0): a Veterinary Cooperative Oncology Group (<scp>VCOG</scp>) consensus document

  Citation: 364

  Authors: S. M., D. H., D. M., C. A.

• Veterinary cooperative oncology group – common terminology criteria for adverse events (VCOG‐CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.1

  Citation: 266

  Authors:

• Response evaluation criteria for peripheral nodal lymphoma in dogs (v1.0)-a veterinary cooperative oncology group (VCOG) consensus document

  Citation: 229

  Authors: D. M., G. M., C., K. A., C. A.

• Veterinary <scp>Cooperative</scp> Oncology Group—Common Terminology Criteria for Adverse Events (<scp>VCOG‐CTCAE</scp> v2) following investigational therapy in dogs and cats

  Citation: 218

  Authors: Amy K., Matthew, R. Timothy, C. Elizabeth, Jenna H., Kaitlin M., Steven, Michelle A., Heidi B., Nicola J., Michelle, Laura E., Kimberly A., Ameet, Sonja, David M., Kristen M., Erika P., John H., Christina

• Preliminary evidence for biologic activity of toceranib phosphate (Palladia^®) in solid tumours

  Citation: 198

  Authors: C., T., N., C., S., M. K., L., K., D. M., B., S., A., F., L., M., D., M. L., M., E., B., T., P., J., V., A., L., J., C., C., S.

• European consensus document on mast cell tumours in dogs and cats

  Citation: 183

  Authors: L., S., P., J. P., P., J., M., J., F., K., D. J.

• Veterinary co‐operative oncology group – common terminology criteria for adverse events (VCOG‐CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.0

  Citation: 177

  Authors:

• Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence^*

  Citation: 154

  Authors: K. U., V. M., M. A., F. S., A.‐M., M., C. M., A. M., J., M. H.

• Histopathologic classification of 171 cases of canine and feline non-Hodgkin lymphoma according to the WHO

  Citation: 130

  Authors: E., A. L., P. S., G.

---